Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Locati

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Current Opinion in Oncology|March 16, 2013
Therapeutic strategies in the management of patients with metastatic anaplastic thyroid cancer: review of the current literatureRoberta Granata, Laura Locati, Lisa Licitra
Expert Opinion on Emerging Drugs|October 8, 2013
Emerging tyrosine kinase inhibitors for head and neck cancerPaolo Bossi, Laura Locati, Lisa Licitra
Targeted Oncology|December 14, 2017
Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution ExperienceSalvatore Alfieri, Cristiana Bergamini, Roberta Granata, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Salivary gland cancer: an update on present and emerging therapiesJulie Carlson, Lisa Licitra, Laura Locati, et al.
Head & Neck|October 9, 2012
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancerPaolo Bossi, Gabriela Kornek, Gaetano Lanzetta, et al.
Oral Oncology|March 26, 2017
Lung metastasectomy in adenoid cystic cancer: Is it worth it?Lara Girelli, Laura Locati, Carlotta Galeone, et al.
Critical Reviews in Oncology/Hematology|July 11, 2003
Cancer of the larynxLisa Licitra, Jacques Bernier, Cesare Grandi, et al.
Tumori|March 17, 2016
Safety of combination treatment with imatinib mesylate, carboplatin, and cetuximab in a patient with multiple cancers: a case reportLaura Pala, Cristiana Bergamini, Martina Imbimbo, et al.
Oral Oncology|July 9, 2014
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancerPaolo Bossi, Laura Locati, Cristiana Bergamini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinomaFederica Perrone, Paolo Bossi, Barbara Cortelazzi, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Current Opinion in Oncology|March 16, 2013
Therapeutic strategies in the management of patients with metastatic anaplastic thyroid cancer: review of the current literatureRoberta Granata, Laura Locati, Lisa Licitra
Expert Opinion on Emerging Drugs|October 8, 2013
Emerging tyrosine kinase inhibitors for head and neck cancerPaolo Bossi, Laura Locati, Lisa Licitra
Targeted Oncology|December 14, 2017
Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution ExperienceSalvatore Alfieri, Cristiana Bergamini, Roberta Granata, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Salivary gland cancer: an update on present and emerging therapiesJulie Carlson, Lisa Licitra, Laura Locati, et al.
Head & Neck|October 9, 2012
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancerPaolo Bossi, Gabriela Kornek, Gaetano Lanzetta, et al.
Oral Oncology|March 26, 2017
Lung metastasectomy in adenoid cystic cancer: Is it worth it?Lara Girelli, Laura Locati, Carlotta Galeone, et al.
Critical Reviews in Oncology/Hematology|July 11, 2003
Cancer of the larynxLisa Licitra, Jacques Bernier, Cesare Grandi, et al.
Tumori|March 17, 2016
Safety of combination treatment with imatinib mesylate, carboplatin, and cetuximab in a patient with multiple cancers: a case reportLaura Pala, Cristiana Bergamini, Martina Imbimbo, et al.
Oral Oncology|July 9, 2014
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancerPaolo Bossi, Laura Locati, Cristiana Bergamini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinomaFederica Perrone, Paolo Bossi, Barbara Cortelazzi, et al.
Pageof 5